<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="tbl0010" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 2
       </label>
<caption id="cap0035">
<simple-para id="spar0065" view="all">
         Clinical outcomes for the entire AS cohort, stratified according to Gleason grade and MRI visibility at baseline.
         
</simple-para>
</caption>

<tgroup cols="7">
<colspec colname="col1"/>
<colspec colname="col2"/>
<colspec colname="col3"/>
<colspec colname="col4"/>
<colspec colname="col5"/>
<colspec colname="col6"/>
<colspec colname="col7"/>
<thead valign="top">
<tr trsep="1">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="center" xmlns="http://www.elsevier.com/xml/common/dtd">
           Gleason grade at baseline
          </td>
<td align="center" xmlns="http://www.elsevier.com/xml/common/dtd">
           All patients
          </td>
<td align="center" colspan="2" nameend="col5" namest="col4" trsep="1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Nonvisible disease
          </td>
<td align="center" colspan="2" nameend="col7" namest="col6" trsep="1" xmlns="http://www.elsevier.com/xml/common/dtd">
           MRI-visible disease
          </td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3 + 3
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3 + 4
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3 + 3
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3 + 4
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            n
           </italic>
</td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           672
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           312
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           65
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           212
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           83
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Mortality
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Prostate cancer–related deaths
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Deaths due to other causes
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           24
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           8
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           4
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           5
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           7
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Total person-year follow-up
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3811
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           All-cause deaths/1000 py (95% CI)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           6.3 (4.1–9.5)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Metastasis
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Nodal
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           5
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Bone
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Total person-year follow-up
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3792
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Total metastatic events/1000 py (95% CI)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2.1 (1.0–4.3)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Treatment
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Number of patients treated
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           216
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           68
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           17
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           82
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           49
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Total person-year follow-up
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3486
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Patients treated/1000 py (95% CI)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           62.0 (54.3–70.6)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           RP
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           62
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           21
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           4
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           23
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           14
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           EBRT (±ADT)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           27
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           8
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           12
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           6
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           ADT alone
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           16
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           5
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           6
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           5
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Brachytherapy
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           5
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Focal
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           106
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           33
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           11
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           38
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           24
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Transition to WW
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           21
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           5
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           9
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           4
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Upgrade to Gleason ≥4 + 3
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Upgrading on follow-up biopsy
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           27
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           11
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           7
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           7
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Total person-year follow-up
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3514
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Upgrading on follow-up biopsies/1000 py (95% CI)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           7.7 (5.2–11.3)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
</tbody>
</tgroup>
<legend>
<simple-para id="spar0070" view="all">
         ADT = androgen deprivation therapy; AS = active surveillance; CI = confidence interval; EBRT = external beam radiotherapy; IQR = interquartile range; MRI = magnetic resonance imaging; py = person-years; RP = radical prostatectomy; WW = watchful waiting.
        </simple-para>
</legend>
<table-footnote id="tblfn0010">

<note-para id="npar0010" view="all">
         Metastasis and prostate cancer–related death were overall rare events, but their rates were higher in the Gleason 3 + 4 and/or “MRI-visible” disease groups. Treatment rates were higher in patients with an MRI lesion at baseline. Most treated patients underwent focal therapy, predominantly high-intensity focused ultrasound. Out of 21 men who transitioned to WW, only one was previously upgraded to Gleason ≥4 + 3, whereas the rest transitioned to WW due to comorbidities, advanced age, or personal preference. IQRs, percentages, or 95% confidence intervals (with continuity correction) are given in parentheses.
        </note-para>
</table-footnote>
</table>
</html>
<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="tbl0005" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 1
       </label>
<caption id="cap0030">
<simple-para id="spar0055" view="all">
         Cohort baseline characteristics (
         <italic>
          n
         </italic>
         = 672).
         
</simple-para>
</caption>

<tgroup cols="5">
<colspec colname="col1"/>
<colspec colname="col2"/>
<colspec colname="col3"/>
<colspec colname="col4"/>
<colspec colname="col5"/>
<thead valign="top">
<tr trsep="1">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="center" colspan="2" nameend="col3" namest="col2" trsep="1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Gleason 3 + 3
          </td>
<td align="center" colspan="2" nameend="col5" namest="col4" trsep="1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Gleason 3 + 4
          </td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            n
           </italic>
</td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           524
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           148
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Likert 4–5 at 1 st mpMRI,
           <italic>
            n
           </italic>
           (%)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           212
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (40.5)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           83
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (56.1)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Age at diagnosis (yr),
           <italic>
            n
           </italic>
           (range)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           62
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (56–66)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           64
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (58.75–70.25)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Presenting PSA (ng/ml),
           <italic>
            n
           </italic>
           (range)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           6
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (4.5–8·4)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           6.9
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (5.17–8.9)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Baseline PSAD (ng/ml
           <sup loc="post">
            2
           </sup>
           ),
           <italic>
            n
           </italic>
           (range)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.12
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (0.09–0.18)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.14
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (0.1–0.22)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Tissue diagnosis,
           <italic>
            n
           </italic>
           (%)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd"/>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           TRUS
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           363
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (69.3)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           90
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (60.8)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           TPM
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           118
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (22.5)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           36
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (24.3)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           TP
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           23
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (4.4)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           13
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (8.8)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           TURP/other
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           20
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (3.8)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           9
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (6.1)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           Targeted
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           101
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (19.3)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           24
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (16.2)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           Positive cores
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (1–3)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           3
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (2–5)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           Total cores
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           12
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (10–22)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           12
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (12–32)
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
<hsp sp="1.0"/>
           MCCL
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1.5
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (1–3)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           4
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           (2–6)
          </td>
</tr>
</tbody>
</tgroup>
<legend>
<simple-para id="spar0060" view="all">
         IQR = interquartile range; MCCL = maximum cancer core length; mpMRI = multiparametric magnetic resonance imaging; PSA = prostate-specific antigen; PSAD = PSA density; TP = transperineal; TPM = template prostate mapping; TRUS = transrectal ultrasonography; TURP = transurethral resection of the prostate.
        </simple-para>
</legend>
<table-footnote id="tblfn0005">

<note-para id="npar0005" view="all">
         Baseline characteristics of men included in the study (
         <italic>
          n
         </italic>
         = 672). Absolute numbers or medians are given for age, PSA, PSAD, number of positive/total cores, and MCCL, with IQRs or percentages in parentheses. The majority of patients had Gleason 3 + 3 cancer and, of those, 40.5% had MRI-visible disease at baseline (defined as a Likert score 4–5 or a clearly outlined lesion as described by the reporting radiologist). Men with Gleason 3 + 4 cancer were older and had higher PSA/PSAD, and a greater proportion had visible disease at baseline compared with the Gleason 3  + 3 group.
        </note-para>
</table-footnote>
</table>
</html>
